Bode-Schnurbus et al evaluated QRS duration as a marker for death in patients with an implantable cardioverter defibrillator (ICD) and heart failure. This can help identify patients who may benefit from closer monitoring and more aggressive therapy. The authors are from the University of Heidelberg in Mannheim.

To read more or access our algorithms and calculators, please log in or register.